Ledipasvir/sofosbuvir fixed-dose combination tablet in Taiwanese patients with chronic genotype 1 hepatitis C virus-Reference-Cited by-同舟云学术

Ledipasvir/sofosbuvir fixed-dose combination tablet in Taiwanese patients with chronic genotype 1 hepatitis C virus

Published:2016-07 Issue:7 Volume:31 Page:1323-1329
ISSN:0815-9319
Container-title:Journal of Gastroenterology and Hepatology
language:en
Short-container-title:Journal of Gastroenterology and Hepatology

Author:

Chuang Wan-Long¹,Chien Rong-Nan²,Peng Cheng-Yuan³,Chang Ting-Tsung⁴,Lo Gin-Ho⁵,Sheen I-Shyan⁶,Wang Horng-Yuan⁷,Chen Jyh-Jou⁸,Yang Jenny C.⁹,Knox Steven J.⁹,Gao Bing⁹,Garrison Kimberly L.⁹,Mo Hongmei⁹,Pang Phillip S.⁹,Hsu Yu-Chun¹⁰,Hu Tsung-Hui¹¹,Chu Chi-Jen¹²,Kao Jia-Horng¹³

Affiliation:

1. Kaohsiung Medical University Hospital, Kaohsiung Medical University; Kaohsiung Taiwan

2. Liver Research Unit; Chang Gung Memorial Hospital-Keelung; Keelung Taiwan

3. Department of Internal Medicine; School of Medicine, China Medical University; Taichung Taiwan

4. Department of Internal Medicine; National Cheng Kung University Hospital; Tainan Taiwan

5. Department of Medicine, E-Da Hospital; Kaohsiung Taiwan

6. Chang Gung Memorial Hospital and Medical College; Chang Gung University; Taoyuan Taiwan

7. Department of Internal Medicine; Mackay Memorial Hospital; Taipei Taiwan

8. Department of Internal Medicine; Chi Mei Hospital; Liouying Tainan Taiwan

9. Gilead Sciences, Inc.; Foster City California USA

10. Department of Gastroenterology; Changhua Christian Hospital; Changhua Taiwan

11. Chang Gung Medical Foundation; Kaohsiung Taiwan

12. Department of Medicine; Taipei Veterans General Hospital and National Yang-Ming University, School of Medicine; Taipei Taiwan

13. National Taiwan University College of Medicine and Hospital; Taipei Taiwan

Publisher

Wiley

Subject

Gastroenterology,Hepatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/jgh.13305/fullpdf

Reference31 articles.

1. Evolving epidemiology of hepatitis C virus;Lavanchy;Clin. Microbiol. Infect.,2011

2. Estimation of seroprevalence of hepatitis B virus and hepatitis C virus in Taiwan from a large-scale survey of free hepatitis screening participants;Chen;J. Formos. Med. Assoc.,2007

3. Hepatitis C virus infection in Taiwan: past, present and future;Kao;J. Formos. Med. Assoc.,2015

4. Hepatitis C virus seromarkers and subsequent risk of hepatocellular carcinoma: long-term predictors from a community-based cohort study;Lee;J. Clin. Oncol.,2010

5. Chronic hepatitis C virus infection increases mortality from hepatic and extrahepatic diseases: a community-based long-term prospective study;Lee;J. Infect. Dis.,2012

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comparison of Glecaprevir/Pibrentasvir and Sofosbuvir/Ledipasvir in Patients with Hepatitis C Virus Genotype 1 and 2 in South Korea;The Korean Journal of Gastroenterology;2024-03-25

2. Efficacy and safety of direct‐acting antiviral therapy for hepatitis C virus in elderly patients (≥65 years old): A systematic review and meta‐analysis;Journal of Viral Hepatitis;2022-04-06

3. Outreach onsite treatment with a simplified pangenotypic direct-acting anti-viral regimen for hepatitis C virus micro-elimination in a prison;World Journal of Gastroenterology;2022-01-14

4. Twelve weeks of ledipasvir/sofosbuvir all‐oral regimen for patients with chronic hepatitis C genotype 2 infection: Integrated analysis of three clinical trials;Hepatology Research;2020-08-11

5. 2020 Taiwan consensus statement on the management of hepatitis C: part (I) general population;Journal of the Formosan Medical Association;2020-06